Tonix Pharmaceuticals Holding Corp.
TNXP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $99 | $25 | $120 | $179 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $8 | $5 | $8 | $8 |
| Inventory | $8 | $14 | $0 | $0 |
| Other Curr. Assets | $4 | $4 | $3 | $3 |
| Total Curr. Assets | $119 | $48 | $131 | $189 |
| Property Plant & Equip (Net) | $43 | $95 | $95 | $51 |
| Goodwill | $0 | $1 | $0 | $0 |
| Intangibles | $0 | $10 | $0 | $0 |
| Long-Term Investments | $1 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | -$0 |
| Other NC Assets | $0 | $1 | $0 | $0 |
| Total NC Assets | $44 | $107 | $95 | $52 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $163 | $154 | $226 | $241 |
| Liabilities | – | – | – | – |
| Payables | $5 | $4 | $8 | $13 |
| Short-Term Debt | $0 | $3 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2 | $3 | $3 | $3 |
| Other Curr. Liab. | $12 | $10 | $6 | $5 |
| Total Curr. Liab. | $18 | $19 | $18 | $22 |
| LT Debt | $5 | $7 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $23 | $0 | $0 |
| Total NC Liab. | $5 | $30 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $23 | $49 | $19 | $22 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$731 | -$601 | -$470 | -$360 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $871 | $706 | $677 | $579 |
| Total Equity | $140 | $106 | $207 | $219 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $163 | $154 | $226 | $241 |
| Net Debt | -$93 | -$15 | -$119 | -$178 |